abstract |
The present invention provides novel inhibitors of hedgehog signaling that are useful as therapeutic agents for treating malignant tumors, wherein the compounds have the general formula I, where A, X, Y, R 1 , R 2 , R 3 , R 4 and n are as described herein. |